Gilead&39;s Descovy HIV Prevention Indication Should Exclude Women US FDA Advisory Cmte. Says
Gilead's Descovy HIV Prevention Indication Should Exclude Women, US FDA Advisory Cmte. Says
18:32 EDT 7 Aug 2019 |
SCRIP
Gilead and the FDA failed women by letting PrEP application get this far without clinical efficacy data in non-transgendered females...
More From BioPortfolio on "Gilead's Descovy HIV Prevention Indication Should Exclude Women, US FDA Advisory Cmte. Says"